Aytu BioPharma (AYTU) News and press releases

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday

1 Jul 22

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.

Cantor Fitzgerald Maintains Overweight on Aytu BioPharma, Lowers Price Target to $5

17 May 22

News, Price Target, Analyst Ratings

Cantor Fitzgerald analyst Jennifer Kim maintains Aytu BioPharma (NASDAQ:AYTU) with a Overweight and lowers the price target from $11 to $5.

Aytu BioPharma Plans To Divest / Discontinue Non Core Assets

17 May 22

Biotech, Earnings, News, Penny Stocks, Health Care, General

Aytu BioPharma: Q3 Earnings Insights

16 May 22

Earnings

Aytu BioPharma (NASDAQ:AYTU) reported its Q3 earnings results on Monday, May 16, 2022 at 04:02 PM. Here's what investors need to know about the announcement. Earnings Aytu BioPharma beat estimated earnings by 34.15%, reporting an EPS of $-0.27 versus an estimate of $-0.41.

Aytu BioScience Q3 Sales $24.20M Up From $13.48M YoY

16 May 22

Earnings, News

Aytu BioScience (NASDAQ:AYTU) reported $24.20 million in sales this quarter. This is a 79.50 percent increase over sales of $13.48 million the same period last year.

Stocks That Hit 52-Week Lows On Friday

6 May 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

On Friday, 1043 companies hit new 52-week lows.

HC Wainwright & Co. Maintains Buy on Aytu BioPharma, Lowers Price Target to $11

28 Apr 22

News, Price Target, Analyst Ratings

HC Wainwright & Co. analyst Vernon Bernardino maintains Aytu BioPharma (NASDAQ:AYTU) with a Buy and lowers the price target from $24 to $11.

Stocks That Hit 52-Week Lows On Wednesday

27 Apr 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

Wednesday's session saw 784 companies set new 52-week lows.

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

27 Apr 22

Pre-Market Outlook, Markets, Movers

Aytu BioPharma Announces Preclinical Data Showing Its Healight UVA Endotracheal Catheter 'delayed the time to development of ventilator-associated pneumonia (VAP) in a novel porcine model'

25 Apr 22

Biotech, General

Preclinical Proof-of-Concept Study Demonstrates Effectiveness of Healight in Delaying Time to Development of Ventilator-Associated Pneumonia ENGLEWOOD, CO / ACCESSWIRE / April 25, 2022 / Aytu BioPharma, Inc.

12 Health Care Stocks Moving In Friday's After-Market Session

22 Apr 22

Movers

Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) stock moved upwards by 16.8% to $1.32 during Friday's after-market session. The company's market cap stands at $37.0 million.

Stocks That Hit 52-Week Lows On Friday

22 Apr 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

On Friday, 431 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Thursday

21 Apr 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

On Thursday, 236 companies hit new 52-week lows.

54 Biggest Movers From Yesterday

20 Apr 22

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers

12 Health Care Stocks Moving In Tuesday's Intraday Session

19 Apr 22

Intraday Update, Markets, Movers

Stocks That Hit 52-Week Lows On Tuesday

19 Apr 22

News, Options, Intraday Update, Markets, Movers, Trading Ideas

On Tuesday, 242 companies hit new 52-week lows.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

19 Apr 22

Pre-Market Outlook, Markets, Movers

Aytu BioPharma Reports Third Quarter 2022 Financial Results and Outlines Key Strategic Priorities

16 May 22

Earnings, Press Releases

Quarterly Net Revenue Increased 79% Year-Over-Year to $24.2 Million, the Highest Revenue in Company HistoryStrategic Priorities Focused on Driving Revenue Growth, Increasing Financial Efficiencies and Performance and

Aytu BioPharma Announces Positive Preclinical Data in Ventilator-Associated Pneumonia with its Novel, Proprietary Healight(TM) Delivery Technology

25 Apr 22

News, Press Releases

Preclinical Proof-of-Concept Study Demonstrates Effectiveness of Healight in Delaying Time to Development of Ventilator-Associated PneumoniaENGLEWOOD, CO / ACCESSWIRE / April 25, 2022 / Aytu BioPharma, Inc.

Thinking about buying stock in Aytu Biopharma, Casa Systems, Highpeak Energy, MRC Global, or DocGo?

19 Apr 22

Opinion, Press Releases

NEW YORK, April 19, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AYTU, CASA, HPK, MRC, and DCGO.

Aytu BioPharma Announces Fast Track Designation Granted to AR101 for the Treatment of Vascular Ehlers-Danlos Syndrome

19 Apr 22

News, Press Releases

ENGLEWOOD, CO / ACCESSWIRE / April 19, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that the U.S. Food and Drug